Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-09

FDA Approved: RIZATRIPTAN BENZOATE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Rizatriptan Benzoate by Rising Pharma Holdings, Inc., authorizing a generic version of rizatriptan benzoate for the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rizatriptan Benzoate (rizatriptan benzoate)

Snippet

SUPPL AP for RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE)